Stockreport

Pallas Capital Backs Monte Rosa Therapeutics, Inc. (GLUE) Amid Growth Prospects [Yahoo! Finance]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF quarter, Pallas Capital Advisors acquired a new position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) through the purchase of 13,182 shares of the company's stock. Acc [Read more]